[1]
|
夏维波, 章振林, 林华, 等. 维生素D及其类似物临床应用共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(1): 1-19.
|
[2]
|
Fiorino, S., Gallo, C., Zippi, M., et al. (2020) Cytokine Storm in Aged People with CoV-2: Possible Role of Vitamins as Therapy or Preventive Strategy. Aging Clinical and Experimental Research, 32, 2115-2131.
https://doi.org/10.1007/s40520-020-01669-y
|
[3]
|
Mohan, M., Cherian, J.J. and Sharma, A. (2020) Exploring Links between Vitamin D Deficiency and COVID-19. PLOS Pathogens, 16, e1008874. https://doi.org/10.1371/journal.ppat.1008874
|
[4]
|
Carlberg, C. (2014) The Physiology of Vitamin D—Far More than Calcium and Bone. Frontiers in Physiology, 5, Article 335. https://doi.org/10.3389/fphys.2014.00335
|
[5]
|
Khazai, N., Judd, S.E. and Tangpricha, V. (2008) Calcium and Vitamin D: Skeletal and Extraskeletal Health. Current Rheumatology Reports, 10, 110-117. https://doi.org/10.1007/s11926-008-0020-y
|
[6]
|
Finklea, J.D., Grossmann, R.E. and Tangpricha, V. (2011) Vita-min D and Chronic Lung Disease: A Review of Molecular Mechanisms and Clinical Studies. Advances in Nutrition, 2, 244-253. https://doi.org/10.3945/an.111.000398
|
[7]
|
Pizzini, A., Aichner, M., Sahanic, S., et al. (2020) Impact of Vitamin D Deficiency on COVID-19—A Prospective Analysis from the CovILD Registry. Nutrients, 12, Article No. 2775. https://doi.org/10.3390/nu12092775
|
[8]
|
Pal, R., Banerjee, M., Bhadada, S.K., et al. (2022) Vitamin D Sup-plementation and Clinical Outcomes in COVID-19: A Systematic Review and Meta-Analysis. Journal of Endocrinolog-ical Investigation, 45, 53-68.
https://doi.org/10.1007/s40618-021-01614-4
|
[9]
|
Grant, W.B., Lahore, H., McDonnell, S.L., et al. (2020) Evi-dence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients, 12, Article No. 988.
https://doi.org/10.3390/nu12040988
|
[10]
|
Hribar, C.A., Cobbold, P.H. and Church, F.C. (2020) Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson’s Disease. Brain Sciences, 10, Ar-ticle No. 284.
https://doi.org/10.3390/brainsci10050284
|
[11]
|
Martín Giménez, V.M., Inserra, F., Tajer, C.D., et al. (2020) Lungs as Target of COVID-19 Infection: Protective Common Molecular Mechanisms of Vitamin D and Melatonin as a New Potential Synergistic Treatment. Life Sciences, 254, Article ID: 117808. https://doi.org/10.1016/j.lfs.2020.117808
|
[12]
|
Crane-Godreau, M.A., Clem, K.J., Payne, P. and Fiering, S. (2020) Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 through Suppression of Antiviral Peptide LL37. Fron-tiers in Public Health, 8, Article 232.
https://doi.org/10.3389/fpubh.2020.00232
|
[13]
|
Hadizadeh, F. (2021) Supplementation with Vitamin D in the COVID-19 Pandemic? Nutrition Reviews, 79, 200-208.
https://doi.org/10.1093/nutrit/nuaa081
|
[14]
|
Aygun, H. (2020) Vitamin D Can Prevent COVID-19 Infec-tion-Induced Multiple Organ Damage. Naunyn-Schmiedeberg’s Archives of Pharmacology, 393, 1157-1160. https://doi.org/10.1007/s00210-020-01911-4
|
[15]
|
de Lucena, T.M.C., da Silva Santos, A.F., de Lima, B.R., et al. (2020) Mechanism of Inflammatory Response in Associated Comorbidities in COVID-19. Diabetes & Metabolic Syn-drome, 14, 597-600.
https://doi.org/10.1016/j.dsx.2020.05.025
|
[16]
|
Bleizgys, A. (2021) Vitamin D and COVID-19: It Is Time to Act. International Journal of Clinical Practice, 75, e13748.
https://doi.org/10.1111/ijcp.13748
|
[17]
|
Sanz, R., Mazzei, L., Santino, N., Ingrasia, M. and Manucha, W. (2020) Vitamin D-Mitochondria Cross-Talk Could Modulate the Signaling Pathway Involved in Hypertension Development: A Translational Integrative Overview. Clínica e Investigación en Arteriosclerosis (English Edition), 32, 144-155. https://doi.org/10.1016/j.artere.2020.02.003
|
[18]
|
Annweiler, C., Cao, Z., Wu, Y., Faucon, E., et al. (2020) Coun-ter-Regulatory “Renin-Angiotensin” System-Based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-Infected Patients. Infectious Disorders-Drug Targets, 20, 407-408. https://doi.org/10.2174/22123989MTA2cNzIlw
|
[19]
|
La Vignera, S., Cannarella, R., Condorelli, R.A., et al. (2020) Sex-Specific SARS-CoV-2 Mortality: Among Hormone- Modulated ACE2 Expression, Risk of Venous Thromboembo-lism and Hypovitaminosis D. International Journal of Molecular Sciences, 21, Article No. 2948. https://doi.org/10.3390/ijms21082948
|
[20]
|
Ilie, P.C., Stefanescu, S. and Smith, L. (2020) The Role of Vitamin D in the Prevention of Coronavirus Disease 2019 Infection and Mortality. Aging Clinical and Experimental Research, 32, 1195-1198.
https://doi.org/10.1007/s40520-020-01570-8
|
[21]
|
Bilezikian, J.P., Bikle, D., Hewison, M., et al. (2020) Mecha-nisms in Endocrinology: Vitamin D and COVID-19. European Journal of Endocrinology, 183, 133-R147. https://doi.org/10.1530/EJE-20-0665
|
[22]
|
Tian, Y. and Rong, L. (2020) Letter: Covid-19, and Vitamin D. Authors’ Reply. Alimentary Pharmacology & Therapeutics, 51, 95-996. https://doi.org/10.1111/apt.15764
|
[23]
|
Quesada-Gomez, J.M., Entrenas-Castillo, M. and Bouillon, R. (2020) Vita-min D Receptor Stimulation to Reduce Acute Respiratory Distress Syndrome (ARDS) in Patients with Coronavirus SARS-CoV-2 Infections: Revised Ms SBMB 2020_166. The Journal of Steroid Biochemistry and Molecular Biology, 202, Article ID: 105719.
https://doi.org/10.1016/j.jsbmb.2020.105719
|
[24]
|
Jain, A., Chaurasia, R., Sengar, N.S., et al. (2020) Analysis of Vitamin D Level among Asymptomatic and Critically Ill COVID-19 Patients and Its Correlation with Inflammatory Markers. Scientific Reports, 10, Article No. 20191.
https://doi.org/10.1038/s41598-020-77093-z
|
[25]
|
Rastogi, A., Bhansali, A., Khare, N., et al. (2022) Short Term, High-Dose Vitamin D Supplementation for COVID-19 Disease: A Randomised, Placebo-Controlled, Study (SHADE Study). Postgraduate Medical Journal, 98, 87-90.
|